Key result
Advancing CKD stages linked to a ~13% progressive increase in short-term SBP variability.
Why the study?
Does short-term blood pressure variability increase with advancing chronic kidney disease stage?
Observational (n=16,546)
Yes
Does short-term blood pressure variability increase with advancing chronic kidney disease stage?
Absolute Event Rate: 15.6% vs 13.8%
p-value: p=<0.001
Short-term systolic blood pressure variability increases progressively with advancing stages of chronic kidney disease, which may contribute to elevated cardiovascular risk in this population.
May heighten CV risk in advancing CKD; hypothesis-generating, prospective studies needed before targeting variability.
OBJECTIVE: Increased BP-variability predicts cardiovascular morbidity and mortality in hypertensives. This study aimed to examine short-term BP-variability according to renal function stage. METHODS: We included 16 546 patients [10 270 (62.1%) without/6276 (38.9%) with CKD Stage 1-5] from the Spanish Ambulatory-Blood-Pressure Monitoring (ABPM) Registry. Stages of CKD were defined according to K/DIGO criteria, based on estimated glomerular filtration rate calculated with the CKD-EPI equation and albumin-to-creatine ratio. BP-variability was assessed with standard deviation (SD), weighted SD (wSD), coefficient of variation (CV), and average real variability (ARV). RESULTS: Compared with those without CKD, a lower proportion of CKD patients were dippers (51.9 versus 39.6%; P < 0.001). Across CKD stages, a progressive decrease in dipper (from 39.1 to 20.4%; P < 0.001) and increase in riser proportion (from 12.3 to 36.7%; P < 0.001) were noted. Patients with CKD had significantly higher SBP SD, wSD, CV and ARV and lower DBP SD compared with those without CKD (P < 0.001). Within CKD Stages, an increasing trend from Stage 1 towards Stage 5 was observed for SBP SD (from 13.8 ± 3.7 to 15.6 ± 5.4 mmHg), wSD (from 12.0 ± 3.2 to 13.9 ± 5.1 mmHg), CV (from 10.4 ± 2.7 to 11.5 ± 4.1%), ARV (from 9.9 ± 2.3 to 11.4 ± 3.2 mmHg); P < 0.001 for all comparisons. DBP SD (P < 0.001), wSD and ARV (P = 0.002) were slightly decreasing, whereas DBP CV increased from Stage 1 to Stage 4 (P < 0.001). In multivariate analysis, male gender, older age, abdominal obesity, diabetes, number of antihypertensive medications, and clinic SBP were independent factors for higher SBP 24-h ARV in CKD. CONCLUSION: An increase in short-term SBP-variability was present with advancing CKD stages in a large cohort. This increased SBP-variability may be involved in the sharp elevation of cardiovascular risk with worsening renal function.
No takes yet. Share an insight, caveat, or question.
Sarafidis et al. (2018) conducted an observational in Hypertension with or without chronic kidney disease (n=16,546). Chronic kidney disease (Stages 1-5) vs. Without chronic kidney disease / lower CKD stages was evaluated on Short-term systolic blood pressure variability (SBP SD) from CKD Stage 1 to Stage 5 (p=<0.001). Advancing chronic kidney disease stages were associated with a progressive increase in short-term systolic blood pressure variability, including SBP SD (from 13.8 to 15.6 mmHg; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: